glp-1 production process , has been the talk of town 2024 Glucagon-like peptide-1 - Wikipedia
Description
STEP 5, the longest trial at 104 weeks, showed that weight loss was sustained over two years of continuous treatment
This would have made an estimated 7 million Americans eligible for GLP-1s, according to the Centers for Medicare & Medicaid Services (CMS)
2026 Apr 1
_1755853304_WNo_587d407.webp)
The GLP-based therapies used during the weight loss intervention included semaglutide (86%), tirzepatide (48%), liraglutide (21%), and dulaglutide (14%), with patients switching between these agents on the basis of insurance coverage and/or medication availability
The plateau typically emerges between weeks 12 and 24 of consistent treatment
Haufe S, Kaminski J, Utz W, Haas V, Mhler A, Daniels MA, et al
